9030624J02Rik Activators are a set of compounds that influence cellular pathways to enhance the functional activity of the protein 9030624J02Rik. Forskolin, by increasing intracellular cAMP, activates protein kinase A (PKA) which can then phosphorylate 9030624J02Rik, potentially enhancing its rolein cellular processes. Ionomycin and A23187, both calcium ionophores, increase intracellular calcium levels, which can activate calcium-dependent kinases capable of phosphorylating 9030624J02Rik, thus activating it. Phorbol 12-myristate 13-acetate (PMA) directly stimulates protein kinase C (PKC), which may phosphorylate and elevate the activity of 9030624J02Rik within its signaling context. Epigallocatechin gallate (EGCG), by inhibiting competitive kinases, facilitates pathways that can lead to 9030624J02Rik activation, ensuring its enhanced participation in cellular dynamics.
The activity of 9030624J02Rik is further influenced by compounds that modulate phosphoinositide 3-kinases (PI3K) and mitogen-activated protein kinases (MAPKs). LY294002, a PI3K inhibitor, can shift cellular signaling towards pathways that activate 9030624J02Rik. Similarly, SB203580 and U0126, which selectively inhibit p38 MAP kinase and MEK1/2, respectively, may result in the activation of compensatory signaling cascades that lead to 9030624J02Rik activation. Sphingosine-1-phosphate (S1P) enhances signaling through its receptors, potentially impacting the pathways that activate 9030624J02Rik. Thapsigargin disrupts calcium homeostasis, which can indirectly activate 9030624J02Rik through calcium-dependent mechanisms. Staurosporine, although a broad kinase inhibitor, may indirectly enhance signaling pathways that activate 9030624J02Rik by inhibiting kinases that negatively regulate these pathways. Lastly, Genistein, by inhibiting specific tyrosine kinases, may also potentiate signaling pathways leading to the activation of 9030624J02Rik, completing the network of chemical influences that bolster 9030624J02Rik's activity.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. The increase in calcium can activate calcium-dependent protein kinases, which may phosphorylate and enhance the activity of 9030624J02Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a variety of substrates, including 9030624J02Rik. The phosphorylation by PKC is likely to increase 9030624J02Rik's activity within its specific signaling pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a kinase inhibitor with a broad range of targets. By inhibiting competitive kinase pathways, EGCG may enhance signaling pathways that lead to the activation of 9030624J02Rik, thereby increasing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is an inhibitor of PI3K, which can shift the balance of downstream signaling pathways, potentially enhancing those that activate 9030624J02Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. Inhibition of p38 may lead to the activation of compensatory pathways that enhance the activity of 9030624J02Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a specific inhibitor of MEK1/2, which may result in the enhancement of alternative signaling pathways that lead to the activation of 9030624J02Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P is a bioactive lipid that can activate sphingosine-1-phosphate receptors and subsequently enhance signaling pathways, potentially leading to the activation of 9030624J02Rik. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels which can activate calcium-dependent pathways, potentially enhancing the activity of 9030624J02Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that, while inhibiting some kinases, may paradoxically enhance signaling pathways that activate 9030624J02Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that, by inhibiting certain tyrosine kinases, may enhance pathways that activate 9030624J02Rik. |